Generic pharmaceutical company Actavis has launched 29 new products in Bulgaria during the first three months of the year.
The company plans to launch a total of 43 new products in Bulgaria during 2008.
The newly launched products include Fosinopril HCT (cardiovascular) and Lisinopril HCT (cardiovascular), both of which were first to market in Bulgaria.
Actavis also released Sertraline (antidepressant), Bicalutamide (oncology) and Irinotecan (oncology), which has also recently marketed in the US.
Of the 29 products, 23 are nutritional supplements (ActaVit® vitamins; Doctor Mom and ActaStyle dietary supplements) and products from the Decubal cosmetics line.
Actavis is a leading generic pharmaceutical company which specialises in the development, manufacture and sale of generic pharmaceuticals. Based in Iceland, the company has operations in 40 countries and 11,000 employees.
For more information on Actavis in Bulgaria visit www.actavis.bg
Leeds, UK, 25.06.2025 – Leeds College of Building proudly announces that one of its apprentices, Ellis…
Kuala Lumpur, Malaysia, 24.06.2025 – Scientex Conference is thrilled to announce the 4th International Conference on…
Conne-de-Labarde, France, 23.06.2026 – Maison Wessman, a leading winery in Southwest France, is excited to…
New Delhi, India – June 16, 2025 – Fine Perforators, a pioneer in filtration screen…
Oslo, Norway – July 9, 2025; Artificial intelligence is not just the future but the…
Radley, Oxfordshire – 18 June 2025 – What started as a simple work experience placement…
